Kantar Health Data Show Zytiga is Most Used First-Line Treatment in Prostate Cancer
NEW YORK, April 23, 2013-ZytigaA is now the most used first-line treatment in Stage IV prostate cancer patients in the United States, according to new findings from CancerMPactA Monthly Drugs and Regimens, which reports oncology drug use by tumor type, stage of disease and line of therapy.
Join the discussion below, or Read more at BioSpace.
#1 Apr 24, 2013
BLOG is awesome, and things you have enlighten, are extremely helpful for prostate health. Such great thought is hard to find
Santo Domingo, Dominican Republic
#2 May 3, 2013
I have been using zytiga, for 41 days, and I could
not, get it on time, so I have to stop it, then after 16 my psa that was 2.19. istarted again and my psa was raised in 16 days to 2.43. is this a normal behavior? can zytiga can increase the psa?
I am in excellent health condition, allmy test are great. will this come back to reduce the psa?
may the lord bless you.
Add your comments below
|Crest Pro-Health Rinse Draws Complaints (May '08)||Jul 14||Anonymous||629|
|NUCYNTA(TM) (tapentadol) CII Immediate Release ... (Jul '09)||Jul 14||Buz||6|
|Study tests new breast cancer drug in African A...||Jul 6||Oh No You Di-nt||1|
|Orlando Democrat: FDA should end ban on gay men...||Jun 29||Nobert||21|
|Politicians, Gay Rights Groups Calls on FDA to ...||Jun 29||RalphB||3|
|Vaccines contain DNA fragments from aborted hum...||Jun 28||Rugilerar||8|
|Procedural delays still keep gay men from donat...||Jun 26||Johnny D||2|
Find what you want!
Search Food and Drug Administration Forum Now
Copyright © 2016 Topix LLC